More than 1 million Americans live with the neurodegenerative brain disorder – and that number is expected to climb ...
Stem cell therapy for dogs is quickly becoming one of the most talked-about advancements in veterinary medicine. As pet owners look for options beyond surgery and long-term medications, regenerative ...
Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. But ...
Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year.
The SPAC agreement values PrimeGen US at $1.5 billion in equity and gives it capital to advance its pre-clinical ...
(Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 clinical study evaluating ...
The new specialist congress highlighted how AI, regenerative medicine, and advanced surgical techniques are reshaping ...
2.5-dimensional cell growth approaches, enhanced by plasmas, are the likely future for applications in medicine and ...
1d
An off-the-shelf immunotherapy for targeting solid tumors: Ready-to-use CAR-NKT cells show promise
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...
Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results